Abstract: Techniques are described for dynamically generating a disaster recovery plan. In an embodiment, a set of topology metadata is determined for a first site on which a multi-tier application is deployed and a second site where the multi-tier application will be activated in the event of switchover/failover. The topology metadata may include metadata that identifies a set of targets associated with a plurality of tiers on the first site on which the multi-tier application is deployed and also on the second site where the multi-tier application would be activated in the event of disaster recovery operation like switchover or failover. Based, at least in part, on the topology metadata for the first site and second site, a disaster recovery plan is generated. The disaster recovery plan includes an ordered set of instructions for deactivating the multi-tier application at the first site and activating the multi-tier application at a second site.

Abstract: Techniques are described for validating a disaster recovery plan. In an embodiment, a request is received to perform a validation of a disaster recovery operation plan that includes a set of instructions for performing a disaster recovery operation with respect to a first site and a second site. In response to receiving the request to perform the validation of the disaster recovery operation plan, a set of one or more validation operations is performed with respect to the disaster recovery operation plan. Based on the set of one or more validation operations, a report is generated that identifies one or more issues that may prevent the disaster recovery operation plan from executing properly.

Abstract: Techniques are described for providing error management capabilities for disaster recovery operations. In an embodiment, first user input is received that identifies a first error mode to assign to a particular step of a disaster recovery plan that includes a set of steps for performing a disaster recovery operation. In response to receiving the first user input, the particular step is associated with the first error mode. In response to determining that an error occurred while processing the particular step of the disaster recovery plan, the error mode that is associated with the particular step is determined. Error handling is performed for the particular step based, at least in part, on the error mode that is associated with the particular step of the disaster recovery plan.

Abstract: Techniques are described for providing error management capabilities for disaster recovery operations. In an embodiment, first user input is received that identifies a first error mode to assign to a particular step of a disaster recovery plan that includes a set of steps for performing a disaster recovery operation. In response to receiving the first user input, the particular step is associated with the first error mode. In response to determining that an error occurred while processing the particular step of the disaster recovery plan, the error mode that is associated with the particular step is determined. Error handling is performed for the particular step based, at least in part, on the error mode that is associated with the particular step of the disaster recovery plan.

Abstract: Techniques are described for dynamically generating a disaster recovery plan. In an embodiment, a set of topology metadata is determined for a first site on which a multi-tier application is deployed and a second site where the multi-tier application will be activated in the event of switchover/failover. The topology metadata may include metadata that identifies a set of targets associated with a plurality of tiers on the first site on which the multi-tier application is deployed and also on the second site where the multi-tier application would be activated in the event of disaster recovery operation like switchover or failover. Based, at least in part, on the topology metadata for the first site and second site, a disaster recovery plan is generated. The disaster recovery plan includes an ordered set of instructions for deactivating the multi-tier application at the first site and activating the multi-tier application at a second site.

Abstract: Techniques are described for validating a disaster recovery plan. In an embodiment, a request is received to perform a validation of a disaster recovery operation plan that includes a set of instructions for performing a disaster recovery operation with respect to a first site and a second site. In response to receiving the request to perform the validation of the disaster recovery operation plan, a set of one or more validation operations is performed with respect to the disaster recovery operation plan. Based on the set of one or more validation operations, a report is generated that identifies one or more issues that may prevent the disaster recovery operation plan from executing properly.

Abstract: The present invention relates to novel methods of synthesis of therapeutic and diagnostic dendrimers. In particular, the present invention is directed to novel dendrimer conjugates, novel methods of synthesizing the same, compositions comprising the conjugates, as well as systems and methods utilizing the conjugates (e.g., in diagnostic and/or therapeutic settings (e.g., for the delivery of therapeutics, imaging, and/or targeting agents (e.g., in disease (e.g., cancer, inflammatory disease) diagnosis and/or therapy, pain therapy, etc.)). Accordingly, dendrimer conjugates of the present invention may further comprise at least two different components for targeting, imaging, sensing, and/or providing a therapeutic or diagnostic material and/or monitoring response to therapy. Furthermore, the novel synthesis methods of certain embodiments of the present invention provide significant advantages with regard to total reaction time and simplicity.

Abstract: Methods for monitoring a patient's health are provided. The methods compromise the steps of providing a website accessible via a computer for monitoring a patient's health; entering the patient's clinical data onto the website; analyzing the data to assign at least one preventive care protocol to the patient; providing a clinic for monitoring the progress of the patient's health; and providing the patient at least one incentive should the patient's health improve.

Abstract: Methods for monitoring a patient's health are provided. The methods compromise the steps of providing a website accessible via a computer for monitoring a patient's health; entering the patient's clinical data onto the website; analyzing the data to assign at least one preventive care protocol to the patient; providing a clinic for monitoring the progress of the patient's health; and providing the patient at least one incentive should the patient's health improve.

Abstract: This invention is directed to triazine derivatives, bicyclic compounds and tricyclic compounds which are selective antagonists for a NPY (Y5) receptor. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention provides a pharmaceutical composition made by combining a therapeutically effective amount of a compound of this invention and a pharmaceutically acceptable carrier. This invention provides a process for making a pharmaceutical composition comprising combining a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. The invention further provides the use of a compound of the invention for the preparation of a pharmaceutical composition for treating an abnormality, wherein the abnormality is alleviated by decreasing the activity of a human Y5 receptor.

Abstract: Storage-stable, bio-available, free-flowing, microemulsified, Omega-three acid-containing oil compositions in the form of microspheres and macrospheres, said compositions consisting essentially of (1) up to about 70% by weight of Omega-three acid-containing oil, and (2) gelatin, in which the oil is microemulsified by the gelatin; processes for their preparation; and product applications (including tablet-type solid forms, dry powders, and spoonable, drinkable emulsions).